연구동향 분석

Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait

Carlos J. Pirola Silvia Sookoian 2022년

논문상세정보
인용/피인용
' Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Auranofin
  • Drug repurposing
  • Fibrosis
  • non alcoholic steatohepatitis
  • non-alcoholic fatty liver disease
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
459 0

0.0%

' Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait' 의 참고문헌

  • The FDA-approved gold drug auranofin inhibits novel coronavirus(SARS-COV-2)replication and attenuates inflammation in human cells
    Rothan HA [2020]
  • Repurposing drugs to target nonalcoholic steatohepatitis
    Sookoian S [2019]
  • PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease
    Sookoian S [2012]
  • PNPLA3, the history of an orphan gene of the potato tuber protein family that found an organ : the liver
    Sookoian S [2014]
  • Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexes
    Sutton BM [1972]
  • Mechanisms of NAFLD development and therapeutic strategies
    Friedman SL [2018]
  • Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease
    Sookoian S [2011]
  • Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease
    Sookoian S [2008]
  • Epigenetics factors in nonalcoholic fatty liver disease
    Pirola CJ [2022]
  • Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo
    Fan C [2014]
  • Current therapies and new developments in NASH
    Dufour JF [2022]
  • Auranofin attenuates non-alcoholic fatty liver disease by suppressing lipid accumulation and NLRP3 inflammasome-mediated hepatic inflammation in vivo and in vitro
    Hwangbo H [2020]
  • Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways
    이승민 [2022]
  • Auranofin Inhibits Overproduction of Pro-Inflammatory Cytokines, Cyclooxygenase Expression and PGE2 Production in Macrophages
    Shinha Han [2008]
  • Auranofin : repurposing an old drug for a golden new age
    Roder C [2015]